The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review

The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review

Background: Irritable bowel syndrome (IBS) is a common gastrointestinal tract disorder, affecting 10–20% of adults worldwide. Mebeverine is an antispasmodic agent indicated for the symptomatic treatment of abdominal pain caused by intestinal smooth muscle spasms and intestinal functional disorders i...

Full description

Bibliographic Details
Main Authors: Jaroslaw Daniluk, Ewa Malecka-Wojciesko, Barbara Skrzydlo-Radomanska, Grazyna Rydzewska
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Clinical Medicine
Subjects:
irritable bowel syndrome
mebeverine
systematic review
Online Access:https://www.mdpi.com/2077-0383/11/4/1044

Similar Items

Similar Items